212 related articles for article (PubMed ID: 38022614)
1. TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines.
Rezaei M; Ghanadian M; Ghezelbash B; Shokouhi A; Bazhin AV; Zamyatnin AA; Ganjalikhani-Hakemi M
Front Immunol; 2023; 14():1267578. PubMed ID: 38022614
[TBL] [Abstract][Full Text] [Related]
2. TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1.
Shapourian H; Ghanadian M; Eskandari N; Shokouhi A; Demirel GY; Bazhin AV; Ganjalikhani-Hakemi M
BMC Cancer; 2024 Jan; 24(1):125. PubMed ID: 38267906
[TBL] [Abstract][Full Text] [Related]
3. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
[TBL] [Abstract][Full Text] [Related]
4. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
Kikushige Y
Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
[TBL] [Abstract][Full Text] [Related]
5. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia.
Soltani M; Ghanadian M; Ghezelbash B; Shokouhi A; Zamyatnin AA; Bazhin AV; Ganjalikhani-Hakemi M
BMC Cancer; 2023 May; 23(1):447. PubMed ID: 37193972
[TBL] [Abstract][Full Text] [Related]
7. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 contributes to the pathogenesis of atopic dermatitis
Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
Front Immunol; 2022; 13():952338. PubMed ID: 35967337
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
11. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
Sakoda T; Kikushige Y
Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p.
Fooladinezhad H; Khanahmad H; Ganjalikhani-Hakemi M; Doosti A
Br J Biomed Sci; 2016 Jul; 73(3):129-133. PubMed ID: 27341144
[TBL] [Abstract][Full Text] [Related]
13. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.
Gonçalves Silva I; Yasinska IM; Sakhnevych SS; Fiedler W; Wellbrock J; Bardelli M; Varani L; Hussain R; Siligardi G; Ceccone G; Berger SM; Ushkaryov YA; Gibbs BF; Fasler-Kan E; Sumbayev VV
EBioMedicine; 2017 Aug; 22():44-57. PubMed ID: 28750861
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.
Gonçalves Silva I; Gibbs BF; Bardelli M; Varani L; Sumbayev VV
Oncotarget; 2015 Oct; 6(32):33823-33. PubMed ID: 26413815
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of TIM-3 suppression by miR-498 and its effect on apoptosis and proliferation rate of HL-60 cell line.
Moghaddam Y; Andalib A; Mohammad-Ganji M; Homayouni V; Sharifi M; Ganjalikhani-Hakemi M
Pathol Res Pract; 2018 Sep; 214(9):1482-1488. PubMed ID: 30107988
[TBL] [Abstract][Full Text] [Related]
16. TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.
Folgiero V; Cifaldi L; Li Pira G; Goffredo BM; Vinti L; Locatelli F
J Hematol Oncol; 2015 Apr; 8():36. PubMed ID: 25886742
[TBL] [Abstract][Full Text] [Related]
17. The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.
Yasinska IM; Sakhnevych SS; Pavlova L; Teo Hansen Selnø A; Teuscher Abeleira AM; Benlaouer O; Gonçalves Silva I; Mosimann M; Varani L; Bardelli M; Hussain R; Siligardi G; Cholewa D; Berger SM; Gibbs BF; Ushkaryov YA; Fasler-Kan E; Klenova E; Sumbayev VV
Front Immunol; 2019; 10():1594. PubMed ID: 31354733
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
Gao L; Yu S; Zhang X
Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.
Zhang W; Zhang Y; He Y; Wang X; Fang Q
Exp Cell Res; 2019 Mar; 376(2):124-132. PubMed ID: 30763585
[TBL] [Abstract][Full Text] [Related]
20. Expression and Clinical Significance of Peripheral Blood IL-17A, IL-22, Tim-3, and gal-9 in Children with Infectious Mononucleosis.
Xu M; Li Y; Cao M; Su Y; Ji Z; Zhou W
Viral Immunol; 2023 Sep; 36(7):458-465. PubMed ID: 37566493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
